AXIM Biotechnologies Inc.

(OTC:AXIM)

Company Description:

AXIM BIotechnologies is an innovative biotechnological company focusing on research, development, and production of pharmaceutical, nutraceutical and cosmetic products within the alternative cannabinoid delivery mechanism space. 

Latest News & Stories on AXIM Biotechnologies Inc. (OTC:AXIM)

AXIM to Present at Annual Symposium in The Netherlands

June 28, 2018

New U.S. Patent Allowance Granted to AXIM Biotechnologies

June 19, 2018

AXIM Enters Thai Distribution Agreement for Cannabinoid Gum

February 6, 2018

Therapix Initiates Non-Clinical Studies for its THC Antibacterial Treatment

October 30, 2017

7 Things Wall Street is Paying Attention to from AXIM's 10-Q Filing

August 22, 2017

AXIM Biotech to Study CBD Gum To Treat Drug-Induced Psychosis

August 2, 2017

AXIM Files Patent on Cannabinoid Gum For Opioid Addiction

June 23, 2017

What You Need to Know About Axim's IBS & MS Clinical Trials

June 19, 2017

AXIM Biotech Receives U.K. Schedule 1 Permit For MedChew Rx Development

May 2, 2017

Axim Biotech to Develop Dronabinol Chewing Gum Product

March 28, 2017

AXIM Biotech to Develop Cannabinoid-Based Treatment for Dry Eye

March 21, 2017

AXIM Biotech Holds Annual Board Meeting

January 25, 2017

AXIM Biotech Enters IBS Clinical Trial for CanChew CBD Chewing Gum

January 18, 2017

Guide to Penny Stocks - Part 2

December 17, 2016

Medical Marijuana, Inc. Investment AXIM Biotechnologies Files Intellectual Property Application for THC Extraction Method

November 29, 2016

Go Long Alternative Cannabis Consumption Methods?

November 23, 2016

AXIM Biotechnologies Publishes Product Pipeline Chart for Pharmaceutical Clinical Trials Program in Cannabinoid R&D

November 3, 2016

Please reload

DMO

© Copyright 2016-2020 Smoke Show Ventures, Inc.

RSS Feed

Disclaimer: Except for the historical information and data presented herein, matters discussed in articles on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future performance or achievements expressed or implied by such coverage. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. Smoke Show Ventures, Inc., which owns The Daily Marijuana Observer, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. Before making specific investment decisions, readers should seek their own professional advice and that of their own professional financial adviser. Smoke Show Ventures, Inc. or its affiliates, which owns The Daily Marijuana Observer, may be compensated for its services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.dailymarijuanaobserver.com/legal-disclaimer/.